Denali Therapeutics (4DN) Q2 2023 Earnings Report
DE:4DN Q2 2023 EPS Results
- Actual EPS
- EUR 1.16
- Consensus EPS
- -EUR 0.62
- Beat/Miss
- Beat by +EUR 1.78
- One Year Ago EPS
- -EUR 0.43
DE:4DN Q2 2023 Revenue Results
- Actual Revenue
- EUR 262.98M
- Expected Revenue
- EUR 35.32M
- Beat/Miss
- Beat by +EUR 227.65M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/08/2023
- Time
- After Close
- Conference Call
- Tuesday, August 8, 2023
DE:4DN Upcoming Earnings
Denali Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:4DN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | ―- | -0.65 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -0.29- | -0.66 | ― | |
| Aug 06, 2026 | 2026 (Q2) | -0.46-0.61 | -0.64 | 5.56% (+0.04) | |
| May 07, 2026 | 2026 (Q1) | -0.65-0.62 | -0.7 | 11.54% (+0.08) | |
| Feb 26, 2026 | 2025 (Q4) | -0.66-0.65 | -0.6 | -8.96% (-0.05) | |
| Nov 06, 2025 | 2025 (Q3) | -0.67-0.66 | -0.56 | -17.46% (-0.10) | |
| Aug 11, 2025 | 2025 (Q2) | -0.63-0.64 | -0.53 | -22.03% (-0.12) | |
| May 06, 2025 | 2025 (Q1) | -0.62-0.70 | -0.61 | -14.71% (-0.09) | |
| Feb 27, 2025 | 2024 (Q4) | -0.71-0.60 | -0.77 | 22.09% (+0.17) | |
| Nov 06, 2024 | 2024 (Q3) | -0.53-0.56 | -0.64 | 12.50% (+0.08) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
